Two of our biggest long term positions had major news within the same three weeks, and on the surface the stories look nothing alike.
META launched a new product, Muse, and it went to #1 on the App Store. INGN sold part of its business for $25 million, and almost nobody outside the home medical equipment trade press wrote about it.
One is a huge company adding something. The other is a small company taking something away. The market reacted to them very differently, but we think they're the same kind of catalyst.
Catalysts That Change How a Company Is Described
Our two layer framework says every trade needs an emotional dislocation and a fundamental thesis. On the thesis side, a lot of people assume a catalyst has to be a big number: a beat, a raise, a new contract.
In our experience, the catalysts that lead to lasting revaluations are usually the ones that change how the market describes the company. Earnings move the estimates. A change in how investors think about the business is what moves the valuation multiple.
Before September, the common view of META was an ad company spending too much on AI. After Muse, more investors are starting to see it as the company with the fastest growing consumer AI app in the world. The underlying business is the same, but the way people talk about it is shifting.
Before September 30, the common view of INGN, among the few people who had one, was a slow growth oxygen company with a shrinking rental unit. After the Rotech deal, the next earnings release can show a business growing faster, with a simpler model and a bigger buyback.
Addition: Why Meta's Launches Have Better Odds
Meta's catalyst is addition. It ships something new, points 3.6 billion daily users at it, and sees what works. Most companies can't do this because acquiring customers for a new product is expensive. For Muse, Meta's main cost was giving up some of its own internal ad slots.
That's why we don't get nervous about Meta "spending too much." When a company owns that much distribution, each new product has better odds than it would anywhere else. Some will fail, and Reality Labs has cost tens of billions. But the products that work, like Reels and now possibly Muse, can scale immediately because the audience is already there.
Addition catalysts reward investors who are patient with the spending. In April the market sold the stock over the cost of these bets. In September it started pricing in the payoff.
Subtraction: Why It Matters in Small Caps
INGN's catalyst is subtraction. Sell the part of the business that drags down growth, turn it into cash and a buyback, and let the rest of the business show what it really looks like.
Subtraction rarely gets a big reaction at first, especially in a stock with little analyst coverage. There's no exciting product, the dollar amount is small, and it can read like a company shrinking.
For a stock the market has mostly ignored, though, subtraction can matter more than addition. The stronger parts of INGN's business were always there. International grew almost 15% last quarter. They were hidden under a declining segment that made the consolidated numbers look flat. Investors who see 3% total growth on a neglected stock usually move on without looking at the segment breakdown. Once the declining segment is gone, the reported numbers show the better trend directly.
How We Play Each One
Addition catalysts: the move often comes quickly and in plain view. META ran roughly 30% in September as Muse took off. The main risk is chasing. We own META from lower prices and don't add into sharp run ups. We add when the market sells off over the cost of the next new bet.
Subtraction catalysts: the move usually comes slowly and later, often at the first earnings report that shows the restated numbers. The opportunity is in the time between the announcement and that report, when the deal is public but the cleaner financials aren't out yet. That's where we are with INGN right now.
What Ties Them Together
Both stories connect to something we wrote about in April: we trade people, not charts. Zuckerberg keeps launching products because Meta's distribution makes them more likely to pay off. Inogen's new leadership is simplifying the company because a stock that few people follow needs a story that is easy to understand.
When we evaluate a catalyst, we look at the people making the decision and ask whether it changes how the market will describe the company. When it does, the valuation tends to follow, though the timing is rarely predictable.